• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·600587.SS
Share

Shinva Medical Instrument Co.,Ltd. Stocks

CN¥ 13.13Last Updated 26.05.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.19B

CN¥ 13.13
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Shinva Medical Instrument Co., Ltd. provides medical instruments and equipment in the People's Republic of China. It offers CSSD integrated solutions, pharmaceutical equipment integrated solutions, radiotherapy integrated solutions, digital operating room integrated solutions, dental integrated solutions, medical environmental protection integrated solutions, experiment animal safeguard integrated solutions, in vitro diagnostic reagents and instruments, and biomedical materials and supplies. The company also provides pharmaceutical machinery and air purifiers. Shinva Medical Instrument Co., Ltd. was founded in 1943 and is headquartered in Zibo, the People's Republic of China.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.05.2026 10:19

Top stories for the morning: oil rises on US and Iran strikes, Dell gets Pentagon contract

28.05.2026 07:00

The founder of Yardeni is not expecting a market bubble. He named the main driver of the year

28.05.2026 03:46

Boeing has been authorized to increase production of the 737 Max. It is its best-selling airliner

28.05.2026 01:26

All three major U.S. indexes hit records - the first time that has happened this year

27.05.2026 23:51

JPMorgan in search of a big deal: Dimon admits to a takeover worth up to $20 billion

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026